P-792 Phase II study of cisplatin plus etoposide over 3 days combinedwith irinotecan and early thoracic radiotherapy (TRT) in patients with limited disease (LD) small cell lung cancer (SCLC), preliminary results
Keyword(s):
Phase Ii
◽